Home				Neurodegenerative Diseases Tx/Dx CI - Y2006 week 43
DATE	SOURCE	OTHER PARTY INVOLVED	INDICATION(S)	HEADLINES - CLICK TO VIEW FULL RELEASE
10/27/06	Schwarz Pharma (DE)		Parkinson	Nine Months Report 2006: Business on Track, Further Progress in R&D
10/27/06	Shire (UK)	Janssen Pharmaceutical (US)	Alzheimer	Excellent third quarter with execution plan on track - upgrading 2006 revenue guidance
10/26/06	Diamyd Medical (SE)	Neurologix (US)	Parkinson	Year End Report for Diamyd Medical AB (publ)
10/26/06	Millennium Pharmaceuticals (US)		Multiple sclerosis	Millennium Achieves Non-GAAP Profitability and Reduces GAAP Net Loss for Third Consecutive Quarter(1)
10/26/06	MultiCell Technologies (US)		Multiple sclerosis	MultiCell Technologies Recaps New Investor Conference Call Discussing Recent Drug Development Initiatives and Strengthened IP Portfolio
10/26/06	Sepracor (US)		Parkinson	Sepracor Announces Third Quarter 2006 Operating Results
10/26/06	The Immune Response (US)	Spelman Research (US)	Multiple sclerosis	Spelman Research Initiates Coverage of The Immune Response Corporation With Price Target of $0.059 Per Share
10/25/06	Affymetrix (US)	Translational Genomics Research Institute (US)	Various	Affymetrix Reports Third Quarter 2006 Results
10/25/06	Elan (IR)		Various	Elan Reports Third Quarter 2006 Financial Results
10/25/06	Pharmos (IL)	Vela Pharmaceuticals (US)	Multiple sclerosis	Pharmos Shareholders Approve Vela Pharmaceuticals Transaction
10/23/06	Amgen (US)		Alzheimer	Amgen's Third Quarter 2006 Adjusted Earnings Per Share, Excluding Stock Option Expense, Increased 22 Percent to $1.04 GAAP Earnings Per Share…
10/23/06	Medivir (SE)		Multiple sclerosis	Medivir, Interim Report, 1 January - 30 September 2006
10/23/06	MultiCell Technologies (US)		Multiple sclerosis	MultiCell Technologies to Host Investor Conference Call to Discuss Progress in Development Programs and Growth of IP Portfolio CEO to Spotlight Lead New..
10/23/06	Santhera Pharmaceuticals (CH)		Parkinson	Santhera announces an Initial Public Offering and subsequent listing on the SWX Swiss Exchange